Literature DB >> 9326165

Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant.

K Kreiss1, M M Mroz, B Zhen, H Wiedemann, B Barna.   

Abstract

OBJECTIVES: To describe relative hazards in sectors of the beryllium industry, risk factors of beryllium disease and sensitisation related to work process were sought in a beryllium manufacturing plant producing pure metal, oxide, alloys, and ceramics.
METHODS: All 646 active employees were interviewed; beryllium sensitisation was ascertained with the beryllium lymphocyte proliferation blood test on 627 employees; clinical evaluation and bronchoscopy were offered to people with abnormal test results; and industrial hygiene measurements related to work processes taken in 1984-93 were reviewed.
RESULTS: 59 employees (9.4%) had abnormal blood tests, 47 of whom underwent bronchoscopy. 24 new cases of beryllium disease were identified, resulting in a beryllium disease prevalence of 4.6%, including five known cases (29/632). Employees who had worked in ceramics had the highest prevalence of beryllium disease (9.0%). Employees in the pebble plant (producing beryllium metal) who had been employed after 1983 also had increased risk, with a prevalence of beryllium disease of 6.4%, compared with 1.3% of other workers hired in the same period, and a prevalence of abnormal blood tests of 19.2%. Logistic regression modelling confirmed these two risk factors for beryllium disease related to work processes and the dependence on time of the risk at the pebble plant. The pebble plant was not associated with the highest gravimetric industrial hygiene measurements available since 1984.
CONCLUSION: Further characterisation of exposures in beryllium metal production may be important to understanding how beryllium exposures confer high contemporary risk of beryllium disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9326165      PMCID: PMC1128986          DOI: 10.1136/oem.54.8.605

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  8 in total

1.  Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease.

Authors:  M M Mroz; K Kreiss; D C Lezotte; P A Campbell; L S Newman
Journal:  J Allergy Clin Immunol       Date:  1991-07       Impact factor: 10.793

2.  Machining risk of beryllium disease and sensitization with median exposures below 2 micrograms/m3.

Authors:  K Kreiss; M M Mroz; L S Newman; J Martyny; B Zhen
Journal:  Am J Ind Med       Date:  1996-07       Impact factor: 2.214

3.  Epidemiology Standardization Project (American Thoracic Society).

Authors:  B G Ferris
Journal:  Am Rev Respir Dis       Date:  1978-12

4.  HLA-DPB1 glutamate 69: a genetic marker of beryllium disease.

Authors:  L Richeldi; R Sorrentino; C Saltini
Journal:  Science       Date:  1993-10-08       Impact factor: 47.728

5.  Epidemiology of beryllium sensitization and disease in nuclear workers.

Authors:  K Kreiss; M M Mroz; B Zhen; J W Martyny; L S Newman
Journal:  Am Rev Respir Dis       Date:  1993-10

6.  Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history.

Authors:  L S Newman; K Kreiss; T E King; S Seay; P A Campbell
Journal:  Am Rev Respir Dis       Date:  1989-06

7.  Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations.

Authors:  K Kreiss; S Wasserman; M M Mroz; L S Newman
Journal:  J Occup Med       Date:  1993-03

8.  Transbronchoscopic lung biopsy in sarcoidosis. Optimal number and sites for diagnosis.

Authors:  R A Roethe; P B Fuller; R B Byrd; D R Hafermann
Journal:  Chest       Date:  1980-03       Impact factor: 9.410

  8 in total
  23 in total

Review 1.  Clinical application of beryllium lymphocyte proliferation testing.

Authors:  Barbara P Barna; Daniel A Culver; Belinda Yen-Lieberman; Raed A Dweik; Mary Jane Thomassen
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

2.  Beryllium's public relations problem: protecting workers when there is no safe exposure level.

Authors:  David Michaels; Celeste Monforton
Journal:  Public Health Rep       Date:  2008 Jan-Feb       Impact factor: 2.792

3.  A novel alternative to environmental monitoring to detect workers at risk for beryllium exposure-related health effects.

Authors:  Elizabeth Fireman; Yehuda Lerman; Moshe Stark; Asher Pardo; Yehuda Schwarz; Michael V Van Dyke; Jill Elliot; Briana Barkes; Lee Newman; Lisa Maier
Journal:  J Occup Environ Hyg       Date:  2014       Impact factor: 2.155

4.  The bioinorganic chemistry and associated immunology of chronic beryllium disease.

Authors:  Brian L Scott; T Mark McCleskey; Anu Chaudhary; Elizabeth Hong-Geller; S Gnanakaran
Journal:  Chem Commun (Camb)       Date:  2008-05-09       Impact factor: 6.222

5.  Efficacy of a program to prevent beryllium sensitization among new employees at a copper-beryllium alloy processing facility.

Authors:  Carrie A Thomas; Rachel L Bailey; Michael S Kent; David C Deubner; Kathleen Kreiss; Christine R Schuler
Journal:  Public Health Rep       Date:  2009 Jul-Aug       Impact factor: 2.792

6.  Progression from beryllium exposure to chronic beryllium disease: an analytic model.

Authors:  Philip Harber; Siddharth Bansal; John Balmes
Journal:  Environ Health Perspect       Date:  2009-02-27       Impact factor: 9.031

7.  Simulation, design, and testing of a high power collimator for the RDS-112 cyclotron.

Authors:  Johanna L Peeples; Matthew H Stokely; Michael C Poorman; Gerald T Bida; Bruce W Wieland
Journal:  Appl Radiat Isot       Date:  2014-12-30       Impact factor: 1.513

8.  Research to Practice Implications of High-Risk Genotypes for Beryllium Sensitization and Disease.

Authors:  Kathleen Kreiss; Ethan D Fechter-Leggett; Erin C McCanlies; Christine R Schuler; Ainsley Weston
Journal:  J Occup Environ Med       Date:  2016-09       Impact factor: 2.162

9.  Performance of the beryllium blood lymphocyte proliferation test based on a long-term occupational surveillance program.

Authors:  Ellen P Donovan; Marc E Kolanz; David A Galbraith; Pamela S Chapman; Dennis J Paustenbach
Journal:  Int Arch Occup Environ Health       Date:  2007-05-05       Impact factor: 3.015

Review 10.  A reconsideration of acute Beryllium disease.

Authors:  Kristin J Cummings; Aleksandr B Stefaniak; M Abbas Virji; Kathleen Kreiss
Journal:  Environ Health Perspect       Date:  2009-04-28       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.